Pacira Biosciences, Inc. (PCRX)
36.34
+0.01
(+0.03%)
USD |
NASDAQ |
Oct 16, 16:00
36.34
0.00 (0.00%)
After-Hours: 20:00
Pacira Biosciences Free Cash Flow (Quarterly) : 56.12M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 56.12M |
| March 31, 2026 | 22.96M |
| December 31, 2025 | 43.47M |
| September 30, 2025 | 56.96M |
| June 30, 2025 | 9.315M |
| March 31, 2025 | 26.91M |
| December 31, 2024 | 31.01M |
| September 30, 2024 | 49.83M |
| June 30, 2024 | 51.65M |
| March 31, 2024 | 46.26M |
| December 31, 2023 | 45.79M |
| September 30, 2023 | 41.04M |
| June 30, 2023 | 40.10M |
| March 31, 2023 | 12.56M |
| December 31, 2022 | 36.54M |
| September 30, 2022 | 37.47M |
| June 30, 2022 | 18.07M |
| March 31, 2022 | 23.11M |
| December 31, 2021 | 14.05M |
| September 30, 2021 | 47.21M |
| June 30, 2021 | 19.58M |
| March 31, 2021 | -0.992M |
| December 31, 2020 | 32.26M |
| September 30, 2020 | 32.02M |
| June 30, 2020 | -24.53M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.516M |
| December 31, 2019 | 21.41M |
| September 30, 2019 | 16.76M |
| June 30, 2019 | 20.71M |
| March 31, 2019 | 1.481M |
| December 31, 2018 | 18.98M |
| September 30, 2018 | 12.18M |
| June 30, 2018 | 11.08M |
| March 31, 2018 | -7.873M |
| December 31, 2017 | 11.86M |
| September 30, 2017 | -8.227M |
| June 30, 2017 | -1.499M |
| March 31, 2017 | -3.61M |
| December 31, 2016 | 12.47M |
| September 30, 2016 | 7.778M |
| June 30, 2016 | -1.327M |
| March 31, 2016 | -10.17M |
| December 31, 2015 | 7.911M |
| September 30, 2015 | -6.787M |
| June 30, 2015 | -4.654M |
| March 31, 2015 | -9.977M |
| December 31, 2014 | 6.032M |
| September 30, 2014 | 3.955M |
| June 30, 2014 | 4.559M |
| March 31, 2014 | -9.996M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Viatris, Inc. | 328.00M |
| Johnson & Johnson | 7.295B |
| Liquidia Corp. | 69.01M |
| Organon & Co. | 31.00M |
| ANI Pharmaceuticals, Inc. | 53.62M |